Insider buying last 90 days
No open-market insider purchases were filed for CAH in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every CAH insider filing, plotted on the chart in Gekko.Open CAH in Gekko
NYSE: CAH
Cardinal Health (CAH) Stock Analysis & Forecast
Nov 4 close
$261.93+8.99 (+3.6%)
Gekko Brief
AI summaryNov 4 closeCardinal Health's stock climbs ahead of its fiscal first-quarter 2027 results, due before the market opens on 5 November, with analysts anticipating higher earnings and revenue from pharmaceutical and specialty operations, though cost pressures in the medical distribution unit are flagged as a potential offset. Separately, the company has agreed to acquire AdaptHealth's Diabetes Health business and the entirety of Strive Medical for approximately $360 million in cash, a move that lets AdaptHealth concentrate on its sleep and respiratory segments. Coverage this week also notes the stock underperformed some competitors on a day of mixed broader-market trading despite posting a daily gain.
The shares closed at $261.93, up 3.6%, sitting above both the 50-day average of $239.16 and the 200-day average of $222.82, with the 50-day above the 200-day. The stock trades near its 52-week high of $262.29, well above its 52-week low of $180.45. The GekkoIndex reads 48.4, placing it in the Neutral zone, down 9.4 points over the last five sessions. Despite the recent run, the price sits 35.1% below Gekko Fair Value of $403.36.
Earnings arrive 5 November, zero days away, falling inside a typical 20-trading-day holding period; the last report beat estimates ($2.60 versus $2.42) but triggered a -1.3% reaction, against an average absolute move of 6.1%. Smart-money and unusual options activity show no recorded signals in their respective windows. Seasonally, the next 20 trading days have averaged +3.1% over five years, rising in three of them. Consensus among 13 firms stands at 11 buy, 2 hold, with a target of $274.87.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Cardinal Health price vs fair value
Close $261.93200-day averageGekko Fair Value $403.36
Cardinal Health quick facts
- Market cap
- $60.65B
- P/E ratio
- 34.7
- Forward P/E
- 19.9
- EPS, TTM
- $7.34
- Revenue, TTM
- $254.2B
- Profit margin
- 0.7%
- Dividend yield
- 0.82%
- Beta
- 0.52
- Volume
- 2.42M avg 1.67M
- 1-year return
- +37.7%
- Typical daily move
- ±2.2%
- Typical 20-day move
- ±4.7%
- 50-day average
- $239.16
- 200-day average
- $222.82
- Next earnings
- Nov 5 before open
- Shares outstanding
- 231.6M
Cardinal Health swing-trade checklist
Cardinal Health scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
- Trendsupportive
Above 50 and 200-day
Close $261.93 is above the 50-day ($239.16) and 200-day ($222.82) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
48.4, Neutral
Reading 48.4 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
35.1% below
Price is 35.1% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskheadwind
Reports today
Reports on Nov 5, 2026, today — inside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+3.1% on average
From this point in the calendar, the next 20 trading days averaged +3.1% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Cardinal Health stock chart and price history
Cardinal Health closed at $261.93 on Nov 4, 2026, +37.7% over the past year, inside a 52-week range of $180.45 to $262.29.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +12.2%
- 3 months
- +10.2%
- 6 months
- +36.8%
- 1 year
- +37.7%
The full CAH chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open CAH in Gekko
Follow Cardinal Health through every session
Put CAH on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track CAH in GekkoFree for 7 days. No credit card required.
About Cardinal Health
Cardinal Health moves medical and pharmaceutical goods to a wide range of healthcare settings, reaching customers not only in the United States but also in Canada, Europe, Asia, and beyond. Hospitals, clinics, pharmacies, surgical centers, labs, doctors' offices, and even people being treated at home all rely on it for supplies and support. Its name is tied to the large-scale handling of drugs and medical products that keep other parts of the healthcare world running.
Two divisions make up its operations. One handles pharmaceuticals, covering brand-name, generic, and specialty drugs plus everyday health items sold over the counter, and it also runs nuclear pharmacy sites, repackages certain drugs and consumer goods, and offers services such as therapy management and pharmacy oversight for hospitals and drug manufacturers. The other division makes and distributes its own line of medical and surgical supplies, from gloves and syringes to wound dressings and protective wear, while also carrying other companies' brands and building supply arrangements for hospitals, surgery centers, and labs.
The company traces back to 1979 and runs its operations from Dublin, Ohio. Its stock trades on the NYSE under the ticker CAH.
- Listed
- NYSE
- Sector
- Distribution services
- Industry
- Medical distributors
- Website
- cardinalhealth.com
Cardinal Health GekkoIndex: the smart money zone
Cardinal Health’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.4, in the Neutral zone, down 9.4 points over five sessions.
48.4Neutral
Down 9.4 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 23 | +2.1% | +6.0% | ||
| Accumulation | 175 | 0.0% | +2.4% | ||
| Neutral (current zone) | 404 | +1.1% | +3.5% | ||
| Distribution | 87 | −0.5% | −0.8% | ||
| Selling | 8 | Too few readings yet | |||
Average CAH share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the CAH price, zone by zone.Track CAH in Gekko
Is Cardinal Health stock overvalued? Gekko Fair Value
Cardinal Health trades 35.1% below Gekko Fair Value of $403.36, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Cardinal Health shares are worth, recalculated every trading day.
$403.36
Gekko Fair Value, Nov 4, 2026
35.1% Undervalued
At the end of Aug 2026 the price was 8.9% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open CAH in Gekko
Cardinal Health insider and Congress trading
No open-market insider purchases were filed for Cardinal Health, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in CAH were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for CAH, plotted on the chart in Gekko.Open CAH in Gekko
Buybacks
Cardinal Health has been buying back its own shares.
- Latest authorization
- $5.00B, Aug 11, 2026
- Bought back, quarter ended Jun 30, 2026
- $350.0M
- As a share of market cap
- 0.58%
- Trailing four quarters
- $1.36B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds CAH.
0added1opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Cardinal Health earnings: next date and track record
Cardinal Health reports on Nov 5, 2026, before the open (today), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 5, 2026
Expected before the open, today
- EPS estimate
- $2.94
- Revenue estimate
- $66.67B
8 of 8reports beat the EPS estimate
±6.1%average move across the report
4 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 11, 2026 AI summary
- What they said
- Cardinal Health reported a strong fiscal 2026 fourth quarter and year, driven by broad-based demand across Pharmaceutical and Specialty Solutions and progress in Global Medical Products and Distribution (GMPD). Management highlighted strong volume, gross profit growth, operating income up 30% year/year, EPS growth (40% quarter, 37% year), and $5 billion adjusted free cash flow for the year. Specialty businesses delivered high growth (above 20%) and Other growth businesses produced double-digit profit growth. Management emphasized continued investments in automation, technology, capacity and targeted M&A, while returning capital to shareholders. Fiscal '27 outlook is constructive: management expects momentum to continue but not at the outsized levels seen in some of fiscal '26, with modest bolt-on M&A carryover benefits. Management reiterated disciplined investment priorities and confidence in execution while acknowledging regulatory and input-cost headwinds (IRA/340B, tariffs, commodity and fuel costs, WACC/pricing impacts).
- Guidance
- Highlights disclosed or referenced for fiscal 2027: - Specialty/Pharma AOI growth guide referenced by analysts as ~8%–11% (management confirmed momentum but not assuming outsized demand). - "Other" segment: revenue growth 11%–13% and profit growth 15%–18%. - Management expects 2–3 percentage points of positive benefit from M&A completed in fiscal '26; no material new M&A assumed for fiscal '27. - Confirmed durable tax rate around ~19% for fiscal '27 (vs. prior higher rate). - Company reaffirmed long-term non-GAAP EPS growth target of ~12%–14% per year (no other updated long-term guidance provided). - IRA/WACC and tariff recovery impacts are modeled into fiscal '27 guidance; commodity/input cost pressures could push results toward the lower end of ranges if sustained.
- Risks flagged
- Key risks discussed: - Regulatory uncertainty: IRA impacts, potential 340B reform, other federal actions affecting pricing and reimbursement. - Tariffs and tariff recovery timing (tariff refund benefit noted as nonrecurring tailwind). - WACC/pricing changes tied to IRA and manufacturer dynamics affecting revenue. - Input cost pressures (diesel, oil-based polymers, resins) and logistics costs that could compress margins or push results toward the low end of guidance. - Potential variability in demand (management assumes strong but not outsized demand).
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 11, 2026 | $2.60 est $2.42 | — est $65.15B | −1.3% |
| Apr 30, 2026 | $3.17 est $2.79 | $60.94B est $62.10B | −3.7% |
| Feb 5, 2026 | $2.63 est $2.37 | $65.63B est $65.08B | +9.4% |
| Oct 30, 2025 | $2.55 est $2.17 | $64.01B est $59.24B | +16.0% |
| Aug 12, 2025 | $2.08 est $2.03 | $60.16B est $60.89B | −6.1% |
| May 1, 2025 | $2.10 est $1.69 | $54.88B est $55.39B | +5.8% |
| Jan 30, 2025 | $1.93 est $1.76 | $55.26B est $55.02B | −3.2% |
| Nov 1, 2024 | $1.88 est $1.62 | $52.28B est $50.90B | +3.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Cardinal Health stock forecast and analyst price targets
Analysts’ average 12-month price target for Cardinal Health is $274.87, +4.9% from the last close, from 13 firms rating the stock in the last 90 days.
$274.87consensus 12-month target, +4.9% from the last close
Now $261.93Avg $274.87
Low $255High $295
Each firm’s latest rating in the last 90 days: 13 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 27 | Barclays | $275 | +5.0% |
| Oct 20 | Mizuho Securities | $280 | +6.9% |
| Oct 16 | UBS | $295 | +12.6% |
| Oct 12 | RBC Capital | $276 | +5.4% |
| Oct 6 | RBC Capital | $276 | +5.4% |
+3.5%average 20-day move after past Neutral readings
+3.1%average move over the next 20 trading days in the last 5 years
±2.2%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Cardinal Health seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Cardinal Health averaged +3.1% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +2.7% | 4 of 5 |
| Next 10 trading days | +2.9% | 4 of 5 |
| Next 15 trading days | +4.0% | 3 of 5 |
| Next 20 trading days | +3.1% | 3 of 5 |
| Next 30 trading days | +1.4% | 4 of 5 |
For scale, CAH’s typical 20-trading-day move in either direction is about 4.7%.
Cardinal Health market cap and key statistics
Cardinal Health’s market cap is $60.65B, with a P/E ratio of 34.7 and revenue of $254.2B over the last twelve months.
Valuation
- Market cap
- $60.65B
- P/E ratio
- 34.7
- Forward P/E
- 19.9
- EPS, TTM
- $7.34
- Gekko Fair Value
- $403.36
Trading
- Volume
- 2.42M
- Avg volume, 20 days
- 1.67M
- 52-week high
- $262.29
- 52-week low
- $180.45
- Shares outstanding
- 231.6M
Financials
- Revenue, TTM
- $254.2B
- Profit margin
- 0.7%
- Return on equity
- 0%
- Quarterly earnings growth, YoY
- +68.8%
Risk and income
- Beta
- 0.52
- Typical daily move
- ±2.2%
- Typical 20-day move
- ±4.7%
- Dividend yield
- 0.82%
Cardinal Health stock news this week
Coverage of Cardinal Health this week reads positive: 11 positive, 8 neutral and 1 negative headlines.
- Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth TodayBenzinga, Nov 4
- Cardinal Health stock rises ahead of fiscal Q1 resultsad-hoc-news.de, Nov 4
- Cardinal Health (CAH) Q3 earnings report preview: what to look forTradingView, Nov 4
- Cardinal Health to buy AdaptHealth unit and Strive Medical for $360Mscanx.trade, Nov 3
- Cardinal Health stock gains ahead of Thursday's earnings testad-hoc-news.de, Nov 3
- Cardinal Health Inc. stock underperforms Monday when compared to competitors despite daily gainsMarketWatch, Nov 2
Cardinal Health peers
Cardinal Health’s 3 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MCKMcKesson | Distribution | 1.7% above |
| CORCencora | Distribution | 19.3% below |
| HSICHenry Schein | Neutral | 6.6% above |
A peer links to its own page where one exists.
Cardinal Health stock FAQ
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is $60.65B at the Nov 4, 2026 close of $261.93, with 231.6M shares outstanding. The shares trade on a P/E ratio of 34.7.
What is the Cardinal Health stock forecast?
The consensus analyst 12-month price target for Cardinal Health is $274.87, +4.9% from the last close. Of the 13 firms that rated the stock in the last 90 days, 11 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Cardinal Health stock overvalued or undervalued?
On Gekko’s estimate Cardinal Health is undervalued: the Nov 4, 2026 close of $261.93 is 35.1% below Gekko Fair Value of $403.36. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Cardinal Health report earnings next?
Cardinal Health is expected to report on Nov 5, 2026, before the market opens (today). Analysts expect earnings of $2.94 per share on revenue of $66.67B. Cardinal Health beat the earnings estimate in 8 of its last 8 reports, moving 6.1% on average across the report.
What is Cardinal Health’s 52-week high and low?
Cardinal Health’s 52-week high is $262.29 and its 52-week low is $180.45; it closed at $261.93 on Nov 4, 2026, +37.7% over the past year.
Is Cardinal Health stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Cardinal Health the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.